Rare diseases
Investigational molecules
Locations
Back to Poland827 clinical trials in Poniatowa, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study on Filgotinib for Children and Teens with Juvenile Idiopathic Arthritis
PolandStudy of Tafasitamab, Lenalidomide, and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma
PolandStudy on Giredestrant and Fulvestrant with CDK4/6 Inhibitor for Patients with ER+ HER2-Negative Advanced Breast Cancer Resistant to Endocrine Therapy
PolandStudy on the Safety and Effectiveness of TP-102 for Treating Diabetic Foot Infections in Patients
PolandStudy on the Safety and Effectiveness of Pembrolizumab for Patients with Kidney Cancer After Surgery
PolandStudy Comparing Tirzepatide and Semaglutide for Weight Loss in Adults with Obesity or Overweight and Related Health Issues
PolandStudy for Patients with Advanced Malignancies: Continued Treatment with Parsaclisib Alone or with Itacitinib, Ruxolitinib, Ibrutinib, or Tafasitamab
PolandStudy of EQU-001 and Placebo for Patients with Uncontrolled Focal Seizures in Epilepsy
PolandStudy of Pembrolizumab and Chemotherapy for Patients with Triple Negative Breast Cancer
PolandStudy on the Effects of Pentosan Polysulfate Sodium for Knee Osteoarthritis Pain in Adults
PolandStudy on the Safety and Effectiveness of CGT9486 for Patients with Nonadvanced Systemic Mastocytosis
PolandStudy on the Effectiveness and Safety of HRO350 for Patients with Mild-to-Moderate Psoriasis
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on hyperlipidemia management, specifically targeting patients at high and very high cardiovascular risk. The research evaluates the effectiveness of rosuvastatin treatments and combination therapies in achieving optimal LDL-C reduction.
These studies aim to establish more effective treatment protocols for patients requiring intensive lipid-lowering therapy.
Comprehensive research evaluating biosimilar treatments for rheumatoid arthritis. The trials compare the efficacy of new biosimilar options with established treatments, focusing on patients with moderate to severe disease conditions.
This research aims to expand treatment options while maintaining high efficacy standards in rheumatoid arthritis management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
